About US
Contact us
-
BerGenBio and Merck to evaluate BGB324 with Keytruda in NSCLC and breast cancerNorwegian-based biopharmaceutical company BerGenBio has signed an agreement to clinically evaluate its lead candidate BGB324 with Merck’s Keytruda (pembrolizumab) in patients with advanced non-small-c2017/3/20
-
Ferring Pharmaceuticals acquires Apricus’ ex-US Vitaros assets and rightsApricus Biosciences has completed the sale of its ex-US assets and rights related to Vitaros, a topical erectile dysfunction cream, to Ferring International Center. The sale is pursuant to a definite2017/3/17
-
Trump's tweet causes pharmaceutical company shares to plungeUS President Donald Trump has pledged to introduce a new system that will help decrease the pricing of drugs and increase competition in the pharmaceutical industry. Without disclosing the details of2017/3/17
-
French biotech MedDay acquires Profilomic's health division to enhance research capabilitiesFrench biotechnology company MedDay has acquired the health division of Profilomic to bolster its current metabolomics research platform SPECMET. Financial details of the transaction have not been di2017/3/16
-
EC grants marketing authorisation for Actelion’s Ledaga to treat MF-CTCLThe European Commission (EC) has granted marketing authorisation for 160mcg of Actelion’s Ledaga (chlormethine gel) to treat mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL). MF-CTCL is a r2017/3/16
-
Scotland’s NPSC and MRC sign MoU to accelerate drug discoveryThe National Phenotypic Screening Centre (NPSC) at the University of Dundee and the Medical Research Council (MRC) Centre for Regenerative Medicine (CRM) at the University of Edinburgh have signed a m2017/3/15
-
Vertex to acquire Concert Pharmaceuticals’ cystic fibrosis drug for $250mUS-based Vertex Pharmaceuticals has signed an agreement to acquire CTP-656, an investigational cystic fibrosis transmembrane conductance regulator (CFTR) potentiator from Concert Pharmaceuticals for u2017/3/15
-
Vernalis and Servier sign oncology drug discovery collaborationUK-based Vernalis and French pharmaceutical company Servier have entered a new oncology drug discovery collaboration. Under the latest two-year agreement, Vernalis' fragment-based and structure-based2017/3/14
-
Sanofi Pasteur and MedImmune to develop and commercialise MEDI8897France-based Sanofi Pasteur has signed an agreement with AstraZeneca’s global biologics research and development arm MedImmune to develop and commercialise a monoclonal antibody known as MEDI8897. ME2017/3/14
-
FDA approves Serenity’s Noctiva nasal spray for frequent night-time urinationThe US Food and Drug Administration (FDA) has approved Noctiva (desmopressin acetate) nasal spray treatment for adults who wake up at least two times every night due to overproduction of urine, a cond2017/3/13